Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10963972 | Vaccine | 2015 | 6 Pages |
Abstract
Reductions in serogroup C IMD among program eligible and ineligible age groups suggest both direct and indirect MCCV vaccine program impact. Continued surveillance of IMD in Ontario is important to further assess MCV4 program impact.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
A.E. Wormsbecker, K. Wong, F.B. Jamieson, N.S. Crowcroft, S.L. Deeks,